Characterisation of clinical canine meticillin-resistant and meticillin-susceptible Staphylococcus pseudintermedius in France

Marisa Haenni; Natasha Alves de Moraes; Pierre Châtre; Christine Médaille; Arshnee Moodley; Jean-Yves Madec

doi:10.1016/j.jgar.2014.02.002

Characterisation of clinical canine meticillin-resistant and meticillin-susceptible Staphylococcus pseudintermedius in France

Marisa Haenni, Natasha Alves de Moraes, Pierre Châtre, Christine Médaille, Arshnee Moodley, Jean-Yves Madec

23 Citationer (Scopus)

Abstract

Staphylococcus pseudintermedius is a frequent pathogen in dogs. The emergence of meticillin-resistant S. pseudintermedius (MRSP), which is concomitantly resistant to nearly all veterinary licensed antibiotics used for systemic treatment in dogs, is a major problem for veterinarians. In France, 16.9% (41/243) of the S. pseudintermedius collected in 2010 were MRSP. They mainly belonged to the multiresistant MLST sequence type ST71, spa type t02, SCCmec type II-III (ST71-t02-II-III) European clone. Moreover, we also report the emergence of multiresistant meticillin-susceptible S. pseudintermedius isolates presenting atypical and/or new spa types. This study highlights the need for surveillance, optimised treatment guidelines and new therapeutic alternatives.

Originalsprog	Engelsk
Tidsskrift	Journal of Global Antimicrobial Resistance
Vol/bind	2
Udgave nummer	2
Sider (fra-til)	119-123
Antal sider	5
ISSN	2213-7165
DOI	https://doi.org/10.1016/j.jgar.2014.02.002
Status	Udgivet - jun. 2014

Adgang til dokumentet

10.1016/j.jgar.2014.02.002

Citationsformater

@article{6064cdbac2c64ee4b035fa9244972cf8,

title = "Characterisation of clinical canine meticillin-resistant and meticillin-susceptible Staphylococcus pseudintermedius in France",

abstract = "Staphylococcus pseudintermedius is a frequent pathogen in dogs. The emergence of meticillin-resistant S. pseudintermedius (MRSP), which is concomitantly resistant to nearly all veterinary licensed antibiotics used for systemic treatment in dogs, is a major problem for veterinarians. In France, 16.9% (41/243) of the S. pseudintermedius collected in 2010 were MRSP. They mainly belonged to the multiresistant MLST sequence type ST71, spa type t02, SCCmec type II-III (ST71-t02-II-III) European clone. Moreover, we also report the emergence of multiresistant meticillin-susceptible S. pseudintermedius isolates presenting atypical and/or new spa types. This study highlights the need for surveillance, optimised treatment guidelines and new therapeutic alternatives.",

author = "Marisa Haenni and {de Moraes}, {Natasha Alves} and Pierre Ch{\^a}tre and Christine M{\'e}daille and Arshnee Moodley and Jean-Yves Madec",

year = "2014",

month = jun,

doi = "10.1016/j.jgar.2014.02.002",

language = "English",

volume = "2",

pages = "119--123",

journal = "Journal of Global Antimicrobial Resistance",

issn = "2213-7165",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Characterisation of clinical canine meticillin-resistant and meticillin-susceptible Staphylococcus pseudintermedius in France

AU - Haenni, Marisa

AU - de Moraes, Natasha Alves

AU - Châtre, Pierre

AU - Médaille, Christine

AU - Moodley, Arshnee

AU - Madec, Jean-Yves

PY - 2014/6

Y1 - 2014/6

N2 - Staphylococcus pseudintermedius is a frequent pathogen in dogs. The emergence of meticillin-resistant S. pseudintermedius (MRSP), which is concomitantly resistant to nearly all veterinary licensed antibiotics used for systemic treatment in dogs, is a major problem for veterinarians. In France, 16.9% (41/243) of the S. pseudintermedius collected in 2010 were MRSP. They mainly belonged to the multiresistant MLST sequence type ST71, spa type t02, SCCmec type II-III (ST71-t02-II-III) European clone. Moreover, we also report the emergence of multiresistant meticillin-susceptible S. pseudintermedius isolates presenting atypical and/or new spa types. This study highlights the need for surveillance, optimised treatment guidelines and new therapeutic alternatives.

AB - Staphylococcus pseudintermedius is a frequent pathogen in dogs. The emergence of meticillin-resistant S. pseudintermedius (MRSP), which is concomitantly resistant to nearly all veterinary licensed antibiotics used for systemic treatment in dogs, is a major problem for veterinarians. In France, 16.9% (41/243) of the S. pseudintermedius collected in 2010 were MRSP. They mainly belonged to the multiresistant MLST sequence type ST71, spa type t02, SCCmec type II-III (ST71-t02-II-III) European clone. Moreover, we also report the emergence of multiresistant meticillin-susceptible S. pseudintermedius isolates presenting atypical and/or new spa types. This study highlights the need for surveillance, optimised treatment guidelines and new therapeutic alternatives.

U2 - 10.1016/j.jgar.2014.02.002

DO - 10.1016/j.jgar.2014.02.002

M3 - Journal article

SN - 2213-7165

VL - 2

SP - 119

EP - 123

JO - Journal of Global Antimicrobial Resistance

JF - Journal of Global Antimicrobial Resistance

IS - 2

ER -

Characterisation of clinical canine meticillin-resistant and meticillin-susceptible Staphylococcus pseudintermedius in France

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater